| 词条 | Adverum Biotechnologies |
| 释义 |
| traded_as = {{NASDAQ|ADVM}} Russell 2000 Component | website = {{URL|https://adverum.com}} }}Avalanche Biotechnologies is a publicly traded (NASDAQ:AAVL)[1] biotechnology company in the NASDAQ Biotechnology Index that is focused on diseases of the eye.[2] This includes macular degeneration,[3] retinal vein occlusion,[4] diabetic macular edema,[5] and others.[6] The company's only drug in clinical trials, AVA-101, designed to treat macular degeneration, had poor results after initial clinical trials in 2015.[5] In 2016 Avalanche Biotechnologies merged with Annapurna Therapeutics to form Advertum Biotechnologies, Inc.[7] References1. ^{{cite web|title=Avalanche Biotechnologies, Inc (AAVL)|url=http://www.nasdaq.com/symbol/aavl|website=NASDAQ.com|accessdate=4 January 2016}} 2. ^{{cite web|title=Avalanche Biotechnologies Announces Leadership Transition|url=https://www.reuters.com/article/idUSnGNX40K1fs+1c8+GNW20150723|website=www.reuters.com|accessdate=4 January 2016}} 3. ^{{cite web|title=Is Avalanche Biotechnologies A Good Buy Now After Phase 2 Results For Its Wet AMD Drug? - Avalanche Biotechnologies (NASDAQ:AAVL)|url=http://seekingalpha.com/article/3297885-is-avalanche-biotechnologies-a-good-buy-now-after-phase-2-results-for-its-wet-amd-drug|website=Seeking Alpha|accessdate=4 January 2016|language=en-US}} 4. ^{{cite web|last1=Burger|first1=Danielle|title=Avalanche Drops as Gene Therapy Data Miss High Expectations|url=https://www.bloomberg.com/news/articles/2015-06-15/avalanche-s-eye-disease-gene-therapy-improves-vision-in-trial|website=Bloomberg.com}} 5. ^1 {{cite web|title=Update on the latest in business:|url=http://wtop.com/health/2015/06/update-on-the-latest-in-business-95/|website=WTOP|publisher=Tegna Media|accessdate=4 January 2016|language=en-US}} 6. ^{{cite web|last1=Burger|first1=Danielle|title=Avalanche drops eye drug trial, takes it back to lab|url=https://www.cnbc.com/2015/08/13/reuters-america-avalanche-drops-eye-drug-trial-takes-it-back-to-lab.html|website=CNBC}} 7. ^{{cite web|url=https://globenewswire.com/news-release/2016/05/12/839388/0/en/Avalanche-Biotechnologies-Closes-Transaction-With-Annapurna-Therapeutics-and-Changes-Name-to-Adverum-Biotechnologies.html|publisher=Global News Wire|date=12 May 2016|access-date= 30 May 2018|title=Avalanche Biotechnologies Closes Transaction With Annapurna Therapeutics and Changes Name to Adverum Biotechnologies}} 2 : Companies listed on NASDAQ|Biotechnology companies |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。